Quantbot Technologies’s Organogenesis Holdings ORGO Stock Holding History

Quantbot Technologies’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,600	Closed	-$80.2K	–	1830
2023 Q4	$80.2K	Buy	+19,600	New	+$54.9K	﹤0.01%	1239
2023 Q3	–	Sell	-17,682	Closed	-$58.7K	–	1845
2023 Q2	$58.7K	Buy	+17,682	New	+$52.3K	﹤0.01%	1290
2023 Q1	–	Sell	-3,000	Closed	-$8.07K	–	1919
2022 Q4	$8.07K	Buy	+3,000	New	+$8.75K	﹤0.01%	1528
2022 Q3	–	Sell	-16,458	Closed	-$80K	–	1953
2022 Q2	$80K	Sell	16,458 -6,442	-28%	-$39.7K	0.01%	1200
2022 Q1	$174K	Buy	+22,900	New	+$177K	0.02%	905
2021 Q4	–	Sell	-1,400	Closed	-$19K	–	1796
2021 Q3	$19K	Buy	1,400 +600	+75%	+$9.32K	﹤0.01%	1280
2021 Q2	$13K	Buy	+800	New	+$14.9K	﹤0.01%	1280

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Quantbot Technologies's ORGO Position: Q1 2024 in Review

Quantbot Technologies sold out of Organogenesis Holdings (ORGO) in Q1 2024, closing a stake of 19,600 shares — an estimated $80.2K sold.

Quantbot Technologies first reported a position in ORGO in Q2 2021 and held it in 7 quarters. The position peaked at $174K in Q1 2022. 124 funds tracked by Wall St. Rank hold ORGO as of Q1 2024.

Quantbot Technologies reported no remaining Organogenesis Holdings position as of Q1 2024 after selling out during the quarter.
Quantbot Technologies sold 19,600 Organogenesis Holdings shares in Q1 2024, an estimated $80.2K.
Quantbot Technologies first reported a position in Organogenesis Holdings in Q2 2021 and held it in 7 quarters.
Quantbot Technologies's Organogenesis Holdings position peaked at $174K in Q1 2022.
124 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.